Neurogene Inc. financial data

Symbol
NGNE on Nasdaq
Location
535 W 24 Th Street, 5 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.96K % +83.9%
Debt-to-equity 8.35 % -51.9%
Return On Equity -29.8 % -15.4%
Return On Assets -27.6 % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.5M shares +4.28%
Common Stock, Shares, Outstanding 14.8M shares +13.6%
Entity Public Float 376M USD +1027%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 21.2M shares +24.9%
Weighted Average Number of Shares Outstanding, Diluted 21.2M shares +24.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 69.7M USD +20.7%
General and Administrative Expense 27.6M USD +45.3%
Operating Income (Loss) -97.3M USD -28.3%
Nonoperating Income (Expense) -24K USD +36.8%
Net Income (Loss) Attributable to Parent -85.1M USD -103%
Earnings Per Share, Basic -4 USD/shares -117%
Earnings Per Share, Diluted -4 USD/shares -1077%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71M USD +6.56%
Cash, Cash Equivalents, and Short-term Investments 312M USD
Other Assets, Current 208K USD -87%
Assets, Current 271M USD +88.3%
Property, Plant and Equipment, Net 13.5M USD -16.1%
Operating Lease, Right-of-Use Asset 2.39M USD -25%
Other Assets, Noncurrent 1.06M USD +34.7%
Assets 288M USD +75.4%
Accounts Payable, Current 1.54M USD -8.31%
Employee-related Liabilities, Current 3.87M USD +12.7%
Accrued Liabilities, Current 9.42M USD -9.72%
Liabilities, Current 14.7M USD -6.9%
Operating Lease, Liability, Noncurrent 7.1M USD -30.2%
Other Liabilities, Noncurrent 51K USD 0%
Liabilities 22.3M USD -16.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -328M USD -35.1%
Stockholders' Equity Attributable to Parent 266M USD +93.2%
Liabilities and Equity 288M USD +75.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD +4.05%
Net Cash Provided by (Used in) Financing Activities 4K USD
Net Cash Provided by (Used in) Investing Activities -45M USD -250%
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 14.8M shares +13.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.8M USD -3837%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71.3M USD +6.53%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -33.3%
Deferred Tax Assets, Valuation Allowance 115M USD +16.2%
Deferred Tax Assets, Gross 116M USD +15.8%
Operating Lease, Liability 12.3M USD -16.9%
Payments to Acquire Property, Plant, and Equipment 780K USD +1100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -34.2M USD +65.5%
Lessee, Operating Lease, Liability, to be Paid 14.8M USD -20.5%
Property, Plant and Equipment, Gross 26.9M USD +1.73%
Operating Lease, Liability, Current 3.07M USD +7.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.7M USD -6.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.99M USD +3.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.48M USD -34.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.24M USD -11.8%
Deferred Tax Assets, Operating Loss Carryforwards 69.3M USD +15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 3.36M USD +28.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.29M USD +1.82%
Operating Lease, Payments 1.31M USD
Additional Paid in Capital 593M USD +56.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.13M USD -4.11%
Deferred Tax Assets, Net of Valuation Allowance 714K USD -24.8%
Share-based Payment Arrangement, Expense 13.3M USD +115%
Interest Expense 3K USD +50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%